Skip to main content
Top
Published in: World Journal of Surgery 9/2004

01-09-2004 | Original Scientific Reports

Effects of Preinjury Administration of Corticosteroids on Pseudointimal Hyperplasia and Cytokine Response in a Rat Model of Balloon Aortic Injury

Authors: Kazuhito Nagasaki, M.D., Kenji Matsumoto, M.D., Munehisa Kaneda, M.D., Tsunehiro Shintani, M.D., Shintaro Shibutani, M.D., Takaya Murayama, M.D., Go Wakabayashi, M.D., Motohide Shimazu, M.D., Makio Mukai, M.D., Masaki Kitajima, M.D.

Published in: World Journal of Surgery | Issue 9/2004

Login to get access

Abstract

Restenosis occurs in approximately one-third of patients with coronary or peripheral vascular disease who undergo balloon angioplasty or a surgical bypass procedure primarily because of the development of pseudointimal hyperplasia (PIH). Corticosteroids were effective in suppressing PIH in several experimental studies, but no clinical studies have been reported. To resolve this discrepancy, we studied the effects of preinjury administration of several doses of methylprednisolone (MP) at targeted times in a rat model of balloon aortic injury. Rats were given either no treatment or an intravenous injection of MP (0.5, 5.0, 50, or 500 mg/kg) 2 hours before aortic injury. Four hours later interleukin-6 (IL-6), IL-10, and macrophage migration inhibitory factor (MIF) concentrations in serum and tissue of injured aortas were assessed. Two weeks after injury, damaged aortas were harvested and studied histopathologically. Compared with results in controls, MP at a dose of 5 mg/kg significantly inhibited increases in plasma and tissue levels of IL-6 and significantly reduced the pseudointimal area, pseudointimal/medial area ratio, and proliferating cell nuclear antigen index in injured vessels. Administration of MP had no significant effect on the IL-10 or MIF level. Thus in a rat model of balloon aortic injury, preinjury administration of MP 5 mg/kg mitigated the development of PIH and cell proliferation and suppressed the postinjury increase in serum and tissue IL-6 concentrations. These results suggest that there is an appropriate dosage as well as appropriate timing for MP administration to suppress PIH.
Literature
1.
go back to reference Taylor, LM,Jr, DeFrang, RD, Harris, EJ,Jr, et al. 1991The association of elevated plasma homocyst(e)ine with progression of symptomatic peripheral arterial diseaseJ. Vasc. Surg.13128136PubMed Taylor, LM,Jr, DeFrang, RD, Harris, EJ,Jr,  et al. 1991The association of elevated plasma homocyst(e)ine with progression of symptomatic peripheral arterial diseaseJ. Vasc. Surg.13128136PubMed
2.
go back to reference Berguer, R, Higgins, RF, Reddy, DJ 1980Intimal hyperplasia: an experimental studyArch. Surg.115332335PubMed Berguer, R, Higgins, RF, Reddy, DJ 1980Intimal hyperplasia: an experimental studyArch. Surg.115332335PubMed
3.
4.
go back to reference Bendtzen, K 1988Interleukin 1, interleukin 6 and tumor necrosis factor in infection, inflammation and immunityImmunol. Lett.19182191CrossRef Bendtzen, K 1988Interleukin 1, interleukin 6 and tumor necrosis factor in infection, inflammation and immunityImmunol. Lett.19182191CrossRef
5.
go back to reference Shenkin, A, Fraser, WD, Series, J, et al. 1989The serum interleukin 6 response to elective surgeryLymphokine Res.8123127PubMed Shenkin, A, Fraser, WD, Series, J,  et al. 1989The serum interleukin 6 response to elective surgeryLymphokine Res.8123127PubMed
6.
go back to reference Haeffner-Cavaillon, N, Roussellier, N, Ponzio, O, et al. 1989Induction of interleukin-1 production in patients undergoing cardiopulmonary bypassJ. Thorac. Cardiovasc. Surg.9811001106PubMed Haeffner-Cavaillon, N, Roussellier, N, Ponzio, O,  et al. 1989Induction of interleukin-1 production in patients undergoing cardiopulmonary bypassJ. Thorac. Cardiovasc. Surg.9811001106PubMed
7.
go back to reference Dahl, JB, Kehlet, H 1991Non-steroidal anti-inflammatory drugs: rationale for use in severe postoperative painBr. J. Anaesth.66703712PubMed Dahl, JB, Kehlet, H 1991Non-steroidal anti-inflammatory drugs: rationale for use in severe postoperative painBr. J. Anaesth.66703712PubMed
8.
go back to reference Hansbrough, JF, Zapata-Sirvent, RL, Bender, EM 1986Prevention of alterations in postoperative lymphocyte subpopulations by cimetidine and ibuprofenAm. J. Surg.151249255CrossRefPubMed Hansbrough, JF, Zapata-Sirvent, RL, Bender, EM 1986Prevention of alterations in postoperative lymphocyte subpopulations by cimetidine and ibuprofenAm. J. Surg.151249255CrossRefPubMed
9.
go back to reference Munck, A, Guyre, PM, Holbrook, NJ 1984Physiological functions of glucocorticoids in stress and their relation to pharmacological actionsEndocr. Rev.52544PubMed Munck, A, Guyre, PM, Holbrook, NJ 1984Physiological functions of glucocorticoids in stress and their relation to pharmacological actionsEndocr. Rev.52544PubMed
10.
go back to reference Engelman, RM, Rousou, JA, Flack, JE,III, et al. 1995Influence of steroids on complement and cytokine generation after cardiopulmonary bypassAnn. Thorac. Surg.60801804CrossRefPubMed Engelman, RM, Rousou, JA, Flack, JE,III,  et al. 1995Influence of steroids on complement and cytokine generation after cardiopulmonary bypassAnn. Thorac. Surg.60801804CrossRefPubMed
11.
go back to reference Hill, GE, Alonso, A, Spurzem, JR, et al. 1995Aprotinin and methylprednisolone equally blunt cardiopulmonary bypass-induced inflammation in humansJ. Thorac. Cardiovasc. Surg.11016581662PubMed Hill, GE, Alonso, A, Spurzem, JR,  et al. 1995Aprotinin and methylprednisolone equally blunt cardiopulmonary bypass-induced inflammation in humansJ. Thorac. Cardiovasc. Surg.11016581662PubMed
12.
go back to reference Teoh, KH, Bradley, CA, Gauldie, J, et al. 1995Steroid inhibition of cytokine-mediated vasodilation after warm heart surgeryCirculation92347353 Teoh, KH, Bradley, CA, Gauldie, J,  et al. 1995Steroid inhibition of cytokine-mediated vasodilation after warm heart surgeryCirculation92347353
13.
go back to reference Kawamura, T, Inada, K, Okada, H, et al. 1995Methylprednisolone inhibits increase of interleukin 8 and 6 during open heart surgeryCan. J. Anaesth.42399403PubMed Kawamura, T, Inada, K, Okada, H,  et al. 1995Methylprednisolone inhibits increase of interleukin 8 and 6 during open heart surgeryCan. J. Anaesth.42399403PubMed
14.
go back to reference Tabardel, Y, Duchateau, J, Schmartz, D, et al. 1996Corticosteroids increase blood interleukin-10 levels during cardiopulmonary bypass in menSurgery1197680PubMed Tabardel, Y, Duchateau, J, Schmartz, D,  et al. 1996Corticosteroids increase blood interleukin-10 levels during cardiopulmonary bypass in menSurgery1197680PubMed
15.
go back to reference Seghaye, M, Duchateau, J, Bruniaux, J, et al. 1996Interleukin-10 release related to cardiopulmonary bypass in infants undergoing cardiac operationsJ. Thorac. Cardiovasc. Surg.111545553PubMed Seghaye, M, Duchateau, J, Bruniaux, J,  et al. 1996Interleukin-10 release related to cardiopulmonary bypass in infants undergoing cardiac operationsJ. Thorac. Cardiovasc. Surg.111545553PubMed
16.
go back to reference Sato, N, Koeda, K, Ikeda, K, et al. 2002Randomized study of the benefits of preoperative corticosteroid administration on the postoperative morbidity and cytokine response in patients undergoing surgery for esophageal cancerAnn. Surg.236184190CrossRefPubMed Sato, N, Koeda, K, Ikeda, K,  et al. 2002Randomized study of the benefits of preoperative corticosteroid administration on the postoperative morbidity and cytokine response in patients undergoing surgery for esophageal cancerAnn. Surg.236184190CrossRefPubMed
17.
go back to reference Huang, W, Richardson, M, Alavi, MZ, et al. 1984Proteoglycan distribution in rat aortic wall following indwelling catheter injuryAtherosclerosis515974PubMed Huang, W, Richardson, M, Alavi, MZ,  et al. 1984Proteoglycan distribution in rat aortic wall following indwelling catheter injuryAtherosclerosis515974PubMed
18.
go back to reference Ogata, T, Kurabayashi, M, Hoshino, Y, et al. 2000Inducible expression of basic transcription element-binding protein 2 in proliferating smooth muscle cells at the vascular anastomotic strictureJ. Thorac. Cardiovasc. Surg.119983989PubMed Ogata, T, Kurabayashi, M, Hoshino, Y,  et al. 2000Inducible expression of basic transcription element-binding protein 2 in proliferating smooth muscle cells at the vascular anastomotic strictureJ. Thorac. Cardiovasc. Surg.119983989PubMed
19.
go back to reference Pan, XM, Nelken, N, Colyvas, N, et al. 1992Inhibition of injury induced intimal hyperplasia by saralasin in ratsJ. Vasc. Surg.15693698CrossRefPubMed Pan, XM, Nelken, N, Colyvas, N,  et al. 1992Inhibition of injury induced intimal hyperplasia by saralasin in ratsJ. Vasc. Surg.15693698CrossRefPubMed
20.
go back to reference Groves, PH, Banning, AP, Penny, WJ, et al. 1995Kinetics of smooth muscle cell proliferation and intimal thickening in a pig carotid model of balloon injuryAtherosclerosis1178396CrossRefPubMed Groves, PH, Banning, AP, Penny, WJ,  et al. 1995Kinetics of smooth muscle cell proliferation and intimal thickening in a pig carotid model of balloon injuryAtherosclerosis1178396CrossRefPubMed
21.
go back to reference Macdonald, RG, Panush, RP, Pepine, CJ 1987Rationale for use of glucocorticoids in modification of restenosis after percutaneous transluminal coronary angioplastyAm. J. Cardiol.6056B60BCrossRefPubMed Macdonald, RG, Panush, RP, Pepine, CJ 1987Rationale for use of glucocorticoids in modification of restenosis after percutaneous transluminal coronary angioplastyAm. J. Cardiol.6056B60BCrossRefPubMed
22.
go back to reference Gordon, JB, Berk, BC, Bettmann, MA, et al. 1987Vascular smooth muscle proliferation following balloon injury is synergistically inhibited by low molecular weight heparin and hydrocortisoneCirculation76213 Gordon, JB, Berk, BC, Bettmann, MA,  et al. 1987Vascular smooth muscle proliferation following balloon injury is synergistically inhibited by low molecular weight heparin and hydrocortisoneCirculation76213
23.
go back to reference Colburn, MD, Moore, WS, Gelabert, HA, et al. 1992Dose responsive suppression of myointimal hyperplasia by dexamethasoneJ. Vasc. Surg.15510518CrossRefPubMed Colburn, MD, Moore, WS, Gelabert, HA,  et al. 1992Dose responsive suppression of myointimal hyperplasia by dexamethasoneJ. Vasc. Surg.15510518CrossRefPubMed
24.
go back to reference Stone, GW, Rutherford, BD, McConahay, DR, et al. 1989A randomized trial of corticosteroids for the prevention of restenosis in 102 patients undergoing repeat coronary angioplastyCathet. Cardiovasc. Diagn.18227231PubMed Stone, GW, Rutherford, BD, McConahay, DR,  et al. 1989A randomized trial of corticosteroids for the prevention of restenosis in 102 patients undergoing repeat coronary angioplastyCathet. Cardiovasc. Diagn.18227231PubMed
25.
go back to reference Pepine, CJ, Hirshfeld, JW, Macdonald, RG, et al. 1990A controlled trial of corticosteroids to prevent restenosis after coronary angioplasty: M-HEART groupCirculation8117531761PubMed Pepine, CJ, Hirshfeld, JW, Macdonald, RG,  et al. 1990A controlled trial of corticosteroids to prevent restenosis after coronary angioplasty: M-HEART groupCirculation8117531761PubMed
26.
go back to reference Pearce, D, Yamamoto, KR 1993Mineralcorticoid and glucocorticoid receptor activities distintinguished by nonreceptor factors at a composite response elementScience25911611165 Pearce, D, Yamamoto, KR 1993Mineralcorticoid and glucocorticoid receptor activities distintinguished by nonreceptor factors at a composite response elementScience25911611165
27.
go back to reference Scheinman, RI, Gualberto, A, Jewell, CM, et al. 1995Characterization of mechanisms involved in transrepression of NF-κB by activated glucocorticoid receptorsMol. Cell. Biol.15943953PubMed Scheinman, RI, Gualberto, A, Jewell, CM,  et al. 1995Characterization of mechanisms involved in transrepression of NF-κB by activated glucocorticoid receptorsMol. Cell. Biol.15943953PubMed
28.
go back to reference Staubbs, SS 1975Corticosteroids and bioavailabilityTransplant. Proct.71119 Staubbs, SS 1975Corticosteroids and bioavailabilityTransplant. Proct.71119
29.
go back to reference Fisher, LE, Ludwig, EA, Wald, JA, et al. 1992Pharmacokinetics and pharmacodynamics of methylprednisolone when administered at 8 AM versus 4 PMClin. Pharmacol. Ther.51677688PubMed Fisher, LE, Ludwig, EA, Wald, JA,  et al. 1992Pharmacokinetics and pharmacodynamics of methylprednisolone when administered at 8 AM versus 4 PMClin. Pharmacol. Ther.51677688PubMed
30.
go back to reference Alegre, ML, Vandenabeele, P, Depierreux, M, et al. 1991Cytokine release syndrome induced by the 145-2C11 anti-CD3 monoclonal antibody in mice: prevention by high doses of methylprednisoloneJ. Immunol.14611841191PubMed Alegre, ML, Vandenabeele, P, Depierreux, M,  et al. 1991Cytokine release syndrome induced by the 145-2C11 anti-CD3 monoclonal antibody in mice: prevention by high doses of methylprednisoloneJ. Immunol.14611841191PubMed
31.
go back to reference Ikeda, U, Ikeda, M, Oohara, T, et al. 1991Interleukin 6 stimulates growth of vascular smooth muscle cells in a PDGF-dependent mannerAm. J. Physiol.260H1713H1717PubMed Ikeda, U, Ikeda, M, Oohara, T,  et al. 1991Interleukin 6 stimulates growth of vascular smooth muscle cells in a PDGF-dependent mannerAm. J. Physiol.260H1713H1717PubMed
32.
go back to reference Hojo, Y, Ikeda, U, Katsuki, T, et al. 2000Interleukin 6 expression in coronary circulation after coronary angioplasty as a risk factor for restenosisHeart848387CrossRefPubMed Hojo, Y, Ikeda, U, Katsuki, T,  et al. 2000Interleukin 6 expression in coronary circulation after coronary angioplasty as a risk factor for restenosisHeart848387CrossRefPubMed
33.
go back to reference Mallat, Z, Heymes, C, Ohan, J, et al. 1999Expression of interleukin-10 in advanced human atherosclerotic plaques: relation to inducible nitric oxide synthase expression and cell deathArterioscler. Thromb. Vasc. Biol.19611616PubMed Mallat, Z, Heymes, C, Ohan, J,  et al. 1999Expression of interleukin-10 in advanced human atherosclerotic plaques: relation to inducible nitric oxide synthase expression and cell deathArterioscler. Thromb. Vasc. Biol.19611616PubMed
34.
go back to reference Fiorentino, DF, Zlotnik, A, Mosmann, TR, et al. 1991IL-10 inhibits cytokine production by activated macrophagesJ. Immunol.14738153822PubMed Fiorentino, DF, Zlotnik, A, Mosmann, TR,  et al. 1991IL-10 inhibits cytokine production by activated macrophagesJ. Immunol.14738153822PubMed
35.
go back to reference Krakauer, T 1995IL-10 inhibits the adhesion of leukocytic cells to IL-1-activated human endothelial cellsImmunol. Lett.456165CrossRefPubMed Krakauer, T 1995IL-10 inhibits the adhesion of leukocytic cells to IL-1-activated human endothelial cellsImmunol. Lett.456165CrossRefPubMed
36.
go back to reference Selzman, CH, Meldrum, DR, Cain, BS, et al. 1998Interleukin-10 inhibits postinjury tumor necrosis factor-mediated human vascular smooth muscle proliferationJ. Surg. Res.80352356CrossRefPubMed Selzman, CH, Meldrum, DR, Cain, BS,  et al. 1998Interleukin-10 inhibits postinjury tumor necrosis factor-mediated human vascular smooth muscle proliferationJ. Surg. Res.80352356CrossRefPubMed
37.
go back to reference Feldman, LJ, Aguirre, L, Ziol, M, et al. 2000Interleukin-10 inhibits intimal hyperplasia after angioplasty or stent implantation in hypercholesterolemic rabbitsCirculation101908916PubMed Feldman, LJ, Aguirre, L, Ziol, M,  et al. 2000Interleukin-10 inhibits intimal hyperplasia after angioplasty or stent implantation in hypercholesterolemic rabbitsCirculation101908916PubMed
38.
go back to reference Yamashita, Y, Shimada, M, Hamatsu, T, et al. 2001Effects of preoperative steroid administration on surgical stress in hepatic resection: prospective randomized trialArch. Surg.136328333CrossRefPubMed Yamashita, Y, Shimada, M, Hamatsu, T,  et al. 2001Effects of preoperative steroid administration on surgical stress in hepatic resection: prospective randomized trialArch. Surg.136328333CrossRefPubMed
39.
go back to reference Bloom, BR, Bennett, B 1966Mechanism of a reaction in vitro associated with delayed-type hypersensitivityScience1538082 Bloom, BR, Bennett, B 1966Mechanism of a reaction in vitro associated with delayed-type hypersensitivityScience1538082
40.
go back to reference Calandra, T, Bernhagen, J, Metz, CN, et al. 1995MIF as a glucocorticoid-induced modulator of cytokine productionNature3776871PubMed Calandra, T, Bernhagen, J, Metz, CN,  et al. 1995MIF as a glucocorticoid-induced modulator of cytokine productionNature3776871PubMed
41.
go back to reference Lin, SG, Yu, XY, Chen, YX, et al. 2000De novo expression of macrophage migration inhibitory factor in atherogenesis in rabbitsCirc. Res.8712021208PubMed Lin, SG, Yu, XY, Chen, YX,  et al. 2000De novo expression of macrophage migration inhibitory factor in atherogenesis in rabbitsCirc. Res.8712021208PubMed
42.
go back to reference Elias, JA, Lentz, V 1990IL-1 and tumor necrosis factor synergistically stimulate fibroblast IL-6 production and stabilize IL-6 messenger RNAJ. Immunol.145161166PubMed Elias, JA, Lentz, V 1990IL-1 and tumor necrosis factor synergistically stimulate fibroblast IL-6 production and stabilize IL-6 messenger RNAJ. Immunol.145161166PubMed
43.
go back to reference Imamura, K, Hayashi, F, Suzumura, A 1992Cytokine production by peripheral blood monocytes/macrophages in patients with multiple sclerosis and its suppression by methylprednisoloneRinsho Shinkeigaku32276280PubMed Imamura, K, Hayashi, F, Suzumura, A 1992Cytokine production by peripheral blood monocytes/macrophages in patients with multiple sclerosis and its suppression by methylprednisoloneRinsho Shinkeigaku32276280PubMed
44.
go back to reference Gabeler, EE, Hillegersberg, R, Statius-Van-Eps, RG, et al. 2002A comparison of balloon injury model of endovascular lesions in rat arteriesB.M.C. Cardiovasc. Disord.216CrossRef Gabeler, EE, Hillegersberg, R, Statius-Van-Eps, RG,  et al. 2002A comparison of balloon injury model of endovascular lesions in rat arteriesB.M.C. Cardiovasc. Disord.216CrossRef
45.
go back to reference Clowes, AW, Reidy, MA, Clowers, MM 1983Kinetics of cellular proliferation after arterial injuryLab. Invest.49327333PubMed Clowes, AW, Reidy, MA, Clowers, MM 1983Kinetics of cellular proliferation after arterial injuryLab. Invest.49327333PubMed
46.
go back to reference Clowes, AW, Reidy, MA, Clowers, MM 1983Mechanisms of stenosis after arterial injuryLab. Invest.49208215PubMed Clowes, AW, Reidy, MA, Clowers, MM 1983Mechanisms of stenosis after arterial injuryLab. Invest.49208215PubMed
Metadata
Title
Effects of Preinjury Administration of Corticosteroids on Pseudointimal Hyperplasia and Cytokine Response in a Rat Model of Balloon Aortic Injury
Authors
Kazuhito Nagasaki, M.D.
Kenji Matsumoto, M.D.
Munehisa Kaneda, M.D.
Tsunehiro Shintani, M.D.
Shintaro Shibutani, M.D.
Takaya Murayama, M.D.
Go Wakabayashi, M.D.
Motohide Shimazu, M.D.
Makio Mukai, M.D.
Masaki Kitajima, M.D.
Publication date
01-09-2004
Publisher
Springer-Verlag
Published in
World Journal of Surgery / Issue 9/2004
Print ISSN: 0364-2313
Electronic ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-004-7457-6

Other articles of this Issue 9/2004

World Journal of Surgery 9/2004 Go to the issue